[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-363072-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-363072-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","incidence-of-hodgkin-and-non-hodgkin-lymphomas-comparison-of-the-military-and-general-population","Incidence of Hodgkin and Non-Hodgkin Lymphomas: Comparison of the Military and General Population","","Background: Lymphoma risk varies across demographics, environmental or occupational exposures, and access to medical care between active-duty service members (ADSM) and the general U.S. population (GUSP). This study compared age-adjusted incidence rates and trends of Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) between these groups. Methods: Using registry data for ages 18–59 diagnosed between 1998 and 2014, incidence rate ratios (IRR) and 95% confidence intervals were calculated with stratified analyses. Results and conclusion emphasize lower lymphoma incidence among ADSM, especially in men and younger individuals.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/incidence-of-hodgkin-and-non-hodgkin-lymphomas-comparison-of-the-military-and-general-population/363072/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/incidence-of-hodgkin-and-non-hodgkin-lymphomas-comparison-of-the-military-and-general-population/363072.png","ImageObject",300,407,{"name":42,"@type":43},"Nguyễn Văn Học","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of comparing lymphoma incidence between ADSM and the general U.S. population?","Question",{"text":63,"@type":64},"To evaluate differences in age-adjusted incidence rates and trends of Hodgkin lymphoma and non-Hodgkin lymphoma between active-duty service members and the general population, accounting for demographic and clinical stratifications.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What data sources and time period were used in the analysis?",{"text":68,"@type":64},"Data were obtained from the Department of War's Central Cancer Registry and the National Cancer Institute's SEER database, covering individuals aged 18–59 diagnosed with lymphoma between 1998 and 2014.",{"name":70,"@type":61,"acceptedAnswer":71},"How did lymphoma incidence differ between ADSM and the general population?",{"text":72,"@type":64},"Lymphoma incidence was lower in ADSM than in GUSP for both HL and NHL, with particularly notable differences in men and younger individuals aged 18–39.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},363072,1790487820,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","Cancer Medicine  \nRESEARCH ARTICLE  OPEN ACCESS   \nIncidence of Hodgkin and Non-Hodgkin Lymphomas: Comparison of the Military and General Population  \nKimberly R. Robins1,2 | Julie A. Bytnar1,2 | Christin B. DeStefano3 | Craig D. Shriver1 | Kangmin Zhu1,2,4  \n1Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA | 2The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. , Bethesda, Maryland, USA | 3Walter Reed National Military Medical Center, Bethesda, Maryland, USA | 4Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA  \nCorrespondence: Kangmin Zhu ([kangmin.zhu@usuhs.edu](kangmin.zhu@usuhs.edu))  \nReceived: 9 December 2025 | Revised: 26 March 2026 | Accepted: 30 March 2026  \nKeywords: Hodgkin lymphoma | incidence | military | non-Hodgkin lymphoma | SEER  \nABSTRACT  \nBackground: Lymphoma risk varies by demographics, environmental/occupational exposures, and medical care between active-duty service members (ADSM) and the general US population (GUSP). This study compared age-adjusted incidence ratesand trends of Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) between these groups.  \nMethods: Data were obtained from the Department of War's Central Cancer Registry and the National Cancer Institute's Surveillance, Epidemiology, and End Results database, including individuals aged 18–59 diagnosed with lymphoma between 1998 and 2014. Incidence rate ratio (IRR) and 95% CIs were calculated to compare the incidence of HL and NHL between ADSMand GUSP, with analyses stratified by sex, race, age, stage, and histology.  \nResults: Lymphoma incidence was lower in ADSM than GUSP (HL: 0.93 [0.86, 1.00]; NHL: 0.82 [0.77, 0.88]); specifically, for men (HL: 0.89 [0 . 82, 0.97]; NHL: 0.69 [0 .64, 0.74]), White (HL: 0.87 [0 . 80, 0.95]; NHL: 0.80 [0 .73, 0. 86]), and Black individuals (HL: 0.82 [0.68, 0.99]; NHL: 0.61 [0.51, 0.73]) . Incidence was lower among ADSM aged 18–39 (HL: 0.91 [0.84, 0.99]; NHL: 0.74 [0.68, 0.81]), but similar at ages 40–59. ADSM had lower HL (early-stage: 0.86 [0.77, 0.96]; nodular lymphocyte predominant: 0.88 [0.80, 0.97]) and NHL (early stage: 0.86 [0.77, 0.96]; advanced stage: 0.87 [0.78, 0.97]; diffuse large B-cell: 0.65 [0.58, 0.74]; other histologies: 0.83 [0.74, 0.93]) incidence.  \nConclusion: Lymphoma incidence was lower in ADSM than GUSP, particularly among men and younger individuals. Based on prior literature, this may be related to the healthier status of ADSM and earlier detection and treatment of medical conditions that can predispose to lymphoma. Diminished differences between the two populations for older individuals may reflect cumulated military-related exposures within a generally healthier population.  \n1 | Introduction  \nIn the United States, approximately 8570 new cases of Hodgkin lymphoma (HL) and 80,620 new cases of non-Hodgkin lymphoma (NHL) are diagnosed annually, representing 0.4% and 4% of all new cancer cases, respectively. HL is more common among younger adults (median age of diagnosis = 39 years), men (2.8 per 100,000 persons, age-adjusted), and non-Hispanic  \nWhite individuals (2.9 per 100,000 persons, age-adjusted). NHL, by contrast, is more prevalent among older adults (median age of diagnosis = 68), but also occurs more frequently among men (22.5 per 100,000 persons, age-adjusted) and non-Hispanic White individuals (20.4 per 100,000 persons, age-adjusted)[1, 2] . Because both HL and NHL are more common in men, groups that are overrepresented in the active-duty service member (ADSM) population and given increasing concerns about  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations","cbCainsAtuRwRK71","https://ap.wps.com/l/cbCainsAtuRwRK71","pdf",913692,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main purpose of comparing lymphoma incidence between ADSM and the general U.S. population?\",\"answer\":\"To evaluate differences in age-adjusted incidence rates and trends of Hodgkin lymphoma and non-Hodgkin lymphoma between active-duty service members and the general population, accounting for demographic and clinical stratifications.\"},{\"question\":\"What data sources and time period were used in the analysis?\",\"answer\":\"Data were obtained from the Department of War's Central Cancer Registry and the National Cancer Institute's SEER database, covering individuals aged 18–59 diagnosed with lymphoma between 1998 and 2014.\"},{\"question\":\"How did lymphoma incidence differ between ADSM and the general population?\",\"answer\":\"Lymphoma incidence was lower in ADSM than in GUSP for both HL and NHL, with particularly notable differences in men and younger individuals aged 18–39.\"}]","Incidence of Hodgkin and Non-Hodgkin Lymphomas: Comparison of the Military and General Population | PDF",1790149885,28,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/46204063797a23f6cd1cfa073021a05e.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/41e97f87ea2abb9e55f2a0486f9b510d.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/766033ac31d5b78255e29765456c0e4f.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56b96188858cb226cc55ae0edb04b928.webp",980,1287]